Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
eXp World Holdings, Inc. (AGNT)
NASDAQReal EstateReal Estate - ServicesSnapshot 2026-11-04
$3.91-8.43%
Close 2026-11-05 · 1-day change
NASDAQReal EstateReal Estate - ServicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.12 → 0.11 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AGNT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Effective leadership drives growth and cost control | A supporting condition in eXp World Holdings, Inc.'s published investment case. The stated target is Sustained progress in execution and cost control in FY26. | Under Pressure | Leadership changes or poor execution slow growth or increase losses | Qualitative: CEO transition (orderly) + earnings miss Orderly CEO succession to Chairman; recent earnings miss; share buyback completed. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk growth and profitability-improvement story, not an established earnings compounder, because the business is still loss-making in the evidence snapshot. The multi-year view is on watch: management priorities are on track, while recent financial performance remains weak versus the industry cohort.
AGNT is valued at a premium to peers, and the expectations gap is positive, meaning the valuation appears to rely on future potential. The priced-in assessment calls that premium unjustified, although fragility is rated low because the evidence points to expensive valuation alone rather than a broader combination of weakness and turbulence. Valuation has also fallen recently, and model confidence is low.
Near term, revenue growth and higher adjusted EBITDA support progress toward management’s 2026 goals, while operating expenses have risen modestly and management’s guidance has narrowed for adjusted EBITDA. However, the company remains loss-making, recent performance is weak, and the estimated risk of another earnings miss is elevated. A CEO transition adds uncertainty, while the snapshot gives little detail on its likely effect.
The multi-year thesis depends on AGNT sustaining revenue growth and translating it into better profitability while keeping expenses disciplined. Near term, a guidance cut or continued earnings misses would weaken that case; the next earnings call is a key test. Fed rate cuts could support the Real Estate sector, while weakness among sector peers could remove that support.
Over the next one to three years, AGNT’s case is progress toward growth and profitability goals, set against loss-making results, elevated execution risk, and a valuation premium that the evidence does not justify. The thesis remains on watch and hinges on management delivering against guidance. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Operating income improves toward positive territory |
| A primary condition in eXp World Holdings, Inc.'s published investment case. The stated target is Operating income improves beyond -$8.79 million in Q1 2026. |
| Improving |
| Operating income worsens or stays below -$8.79 million in FY26 |
Operating income: $1.641M FY2026-Q2; GAAP. Published target: Operating income improves beyond -$8.79 million in Q1 2026. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 20261,641,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches about $5.15 billion in 2026 | A primary condition in eXp World Holdings, Inc.'s published investment case. The stated target is ~$5.15 billion. | Under Pressure | Revenue falls below $4.85 billion in FY26 | Revenue: $1.45B FY2026-Q2; GAAP. Published target: ~$5.15 billion. Annual target cannot be compared with a quarterly or TTM observation. Aug 4, 20261,449,548,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.35 → $0.11 · observed estimates
$5.23B → $5.39B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-25 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-26 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-27 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-28 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-29 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-30 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-07-31 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-01 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-02 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-03 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-04 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-05 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-06 | $0.35 | $5,234,727,670 | 1 / 3 |
| 2026-08-07 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-08 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-09 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-10 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-11 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-12 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-13 | $0.30 | $5,359,600,330 | 1 / 3 |
| 2026-08-14 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-15 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-16 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-17 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-18 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-19 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-20 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-21 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-22 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-23 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-24 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-25 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-26 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-27 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-28 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-29 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-30 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-08-31 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-01 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-02 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-03 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-04 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-05 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-06 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-07 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-08 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-09 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-10 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-11 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-12 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-13 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-14 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-15 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-16 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-17 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-18 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-19 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-20 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-21 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-22 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-23 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-24 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-25 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-26 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-27 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-28 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-29 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-09-30 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-10-01 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-10-02 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-10-03 | $0.06 | $5,359,607,000 | 1 / 2 |
| 2026-10-04 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-05 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-06 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-07 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-08 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-09 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-10 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-11 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-12 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-13 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-14 | $0.12 | $5,391,500,000 | 1 / 2 |
| 2026-10-15 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-16 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-17 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-18 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-19 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-20 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-21 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-22 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-23 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-24 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-25 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-26 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-27 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-28 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-29 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-30 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-10-31 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-11-01 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-11-02 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-11-03 | $0.11 | $5,394,733,333 | 1 / 2 |
| 2026-11-04 | $0.11 | $5,394,733,333 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.